# Xeris Biopharma Holdings, Inc. (XERS) SEC filings and CIK

Canonical: https://sec-api.dev/companies/xers

> XERS’s SEC CIK is 0001867096 (1867096).

Insider transactions in the latest quarter: 14 (0 purchases, 11 sales). https://sec-api.dev/insider-trading/xers

| Filed | Form | Filing |
| --- | --- | --- |
| 2026-11-06 | 4 | https://www.sec.gov/Archives/edgar/data/1867096/000186709626000119/0001867096-26-000119-index.htm |
| 2026-10-30 | SCHEDULE 13G/A | https://www.sec.gov/Archives/edgar/data/1867096/000210011926001642/0002100119-26-001642-index.htm |

API: GET https://sec-api.dev/api/v1/filings?cik=1867096

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.
API: https://sec-api.dev/docs · ChatGPT app: https://chatgpt.com/plugins/plugin_asdk_app_6ae0ef2436ac8191941dae8a4d732669 · Free key: https://sec-api.dev/sign-up